KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to -$14.2 million.

  • Chemed's Cash from Investing Activities rose 2313.01% to -$14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.9 million, marking a year-over-year increase of 6091.95%. This contributed to the annual value of -$143.9 million for FY2024, which is 13731.24% down from last year.
  • As of Q3 2025, Chemed's Cash from Investing Activities stood at -$14.2 million, which was up 2313.01% from -$15.5 million recorded in Q2 2025.
  • Chemed's Cash from Investing Activities' 5-year high stood at -$10.4 million during Q3 2021, with a 5-year trough of -$93.5 million in Q2 2024.
  • Over the past 5 years, Chemed's median Cash from Investing Activities value was -$15.4 million (recorded in 2023), while the average stood at -$19.2 million.
  • As far as peak fluctuations go, Chemed's Cash from Investing Activities crashed by 46587.98% in 2024, and later surged by 8344.08% in 2025.
  • Chemed's Cash from Investing Activities (Quarter) stood at -$14.0 million in 2021, then plummeted by 38.75% to -$19.5 million in 2022, then skyrocketed by 40.12% to -$11.7 million in 2023, then decreased by 7.28% to -$12.5 million in 2024, then dropped by 13.69% to -$14.2 million in 2025.
  • Its Cash from Investing Activities was -$14.2 million in Q3 2025, compared to -$15.5 million in Q2 2025 and -$13.7 million in Q1 2025.